Article ID Journal Published Year Pages File Type
3848367 American Journal of Kidney Diseases 2013 6 Pages PDF
Abstract
Increasing the ESA dose at hospitalization in hemodialysis patients is associated with higher risk of exceeding recommended hemoglobin targets, but does not appear to be associated with the need for transfusion, risk of cardiovascular outcomes, or death.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Preview
Association of a Change in Erythropoiesis-Stimulating Agent Dose During Hospitalization and Subsequent Hemoglobin Levels and Transfusions in Hemodialysis Patients
Authors
, , , , , , , , , , , , , , , ,